Objectives:

1. Describe the hypothesis for melatonin use in delirium prevention.

2. Discuss the outcomes, strengths, and limitations of existing trials of melatonin for delirium prevention

3. Apply conclusions from existing trials to clinical decision making in a patient case

 

Session date: 
10/13/2016 - 8:00am to 9:00am CDT
Location: 
UCMC W-717
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation
Please login or create an account to proceed.
Speaker Name: 
Emily Escue, MD